Skip to content

Digital-technology Based Interventions on Treatment of Migraine.

Digital-technology Based Interventions on Treatment of Migraine.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05458817
Acronym
Migrevention
Enrollment
600
Registered
2022-07-14
Start date
2022-01-01
Completion date
2025-05-31
Last updated
2023-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine, Primary Headache Disorders

Brief summary

The main aim of the research: To develop an interdisciplinary treatment platform based on digital technology and test the operation and effectiveness of digital interventions in comparison with conventional multidisciplinary treatment or treatment standards (incl. Paper diary, nurse counseling, physiotherapy, cognitive-behavioral therapy).

Detailed description

Aims and purpose: The main aim of the research: To develop an interdisciplinary treatment platform based on digital technology and test the operation and effectiveness of digital interventions in comparison with conventional multidisciplinary treatment or treatment standards (incl. Paper diary, nurse counseling, physiotherapy, cognitive-behavioral therapy). Sub-aims: To evaluate the effectiveness of interventions based on digital technology and their impact on the quality of life, comparing them with the interventions or treatment standards performed by ordinary specialists. Assess the applicability and accessibility of digital technology-based interventions in the healthcare system against a treatment standard. Determine the profile of patients (demographic and clinical indicators). Identify restrictions on the use of digital interventions. Evaluate patient compliance, non-specific treatment factors such as therapeutic relationship, and treatment credibility against the treatment standard. Evaluate patient satisfaction with treatment methods and impact on treatment outcomes. Assess the satisfaction of professionals with the implementation of a digital multidisciplinary treatment platform in patients. Assess the use and generalization of digitally acquired skills in everyday practice. Determine if and how much clinical contact is needed for digital-based interventions to be effective. Evaluate cost-effectiveness against the standard of treatment. Assess the willingness to pay for the use of an effective headache treatment platform.

Interventions

Patients in the digital group complete the tests in the patient's mobile application and/or in the Internet-based research environment of the Institute of Psychology of the University of Tartu kaemus.psych.ut.ee. Patients and specialists of the control group fill in the tests and the satisfaction questionnaire in the kaemus.psych.ut.ee environment.

Sponsors

University of Tartu
CollaboratorOTHER
Tartu University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

1. diagnosed migraine, frequent episodic, headache days a month 8-14 days; 2. patient age 18-64 years; 3. very good command of the Estonian language both orally and in writing.

Exclusion criteria

1. headaches lasting less than 8 days and more than 14 days per month; 2. all other primary and/or secondary diagnoses of headache; 3. under the age of 18 or over 64; 4. currently severe depression; 5. psychotic disorders; 6. pregnancy and lactation; 7. severe somatic disease; 8. severe organic mental disorders; 9. other chronic pain; 10. addictive disorders.

Design outcomes

Primary

MeasureTime frameDescription
headache frequency3 monthsheadache diary: number of headache days per month

Secondary

MeasureTime frameDescription
The effect of headaches on everyday life3 monthsHeadache Impact Test (HIT-6)
Pain acceptance Pain acceptance Pain acceptance3 monthsChronic Pain Acceptance Questionnaire-Revised (CPAQ-R)
Pain-related anxiety3 monthsPain Anxiety Symptoms Scale (PASS)
Health related quality of life3 monthsEUROHIS-QOL 8-item index (shortened version of the World Health Organization Quality of Life Instrument-Abbreviated Version)
Patient satisfaction with treatment 13 monthsHeadache Attributed Lost Time (HALT)
Patient satisfaction with treatment 23 monthsHeadache Under-Response to Treatment (HURT)
medication use3 monthsheadache diary: number of headache days per month
Patient satisfaction with treatment 46 monthsHeadache Under-Response to Treatment (HURT)
Patient satisfaction with treatment 59 monthsHeadache Attributed Lost Time (HALT)
Patient satisfaction with treatment 69 monthsHeadache Under-Response to Treatment (HURT)
Cost-effectiveness 19 monthsdatabases of the Estonian Health Insurance Fund, the Social Insurance Board and the Institute for Health Development (insurance costs per patient - sick leaves compensation)
Cost-effectiveness 29 monthsdatabases of the Estonian Health Insurance Fund, the Social Insurance Board and the Institute for Health Development (insurance costs per patient - medications reimbursement)
Patient's willingness to pay for headache treatment9 monthsWillingness to pay bidding game
Patient satisfaction with treatment 36 monthsHeadache Attributed Lost Time (HALT)

Countries

Estonia

Contacts

Primary ContactMark Braschinsky, MD, PhD
mark.braschinsky@kliinikum.ee+3727318501
Backup ContactKatrin Kaarna, MD
Katrin.Kaarna@kliinikum.ee+3727374119

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026